Global pharmaceutical company Mallinckrodt Plc (NYSE: MNK) has entered an agreement to buy Rockville’s Sucampo Pharmaceuticals Inc. (NASDAQ: SCMP) for $1.2 billion including debt.
{iframe}https://www.bizjournals.com/washington/news/2017/12/26/sucampo-pharmaceuticals-to-be-acquired-in-1-2b.html?ana=e_me_set1&s=newsletter&ed=2017-12-26&u=wjGEy67ABoSnsLErlc5ry0j5hx3&t=1514561819&j=79398221{/iframe}